Please login to the form below

Live panel discussion: Should diverse representation in UK clinical trials be mandatory?

This online event is being held by Innovative Trials, COUCH Health, and Egality Health.  Three organisations who are working to improve diversity in clinical trials.

Live panel discussion |  Tuesday 10 November 2020  |  12:30–14:00 GMT / 07:30–09:00 EST

Sign up to attend the discussion here: https://www.clinicaltrialdiversity.info/

In 2019, of the ~46,000 clinical research volunteers involved in clinical trials that resulted in novel drug approvals only 18% were Hispanic, 9% were African American, and 9% were Asian. Patient diversity is a problem that exists in clinical trials. Participants across all therapeutic areas have tended to be Caucasian and male.

There is a recognised need to challenge the disproportionate representation in research that affects population health. In the US, for example, the FDA is placing increasing pressure on pharma companies to run trials with patients who better resemble the overall population; a scramble is on to make trials more diverse.

The FDA guidance on patient diversity does not specifically dictate what companies should do to make their trials more diverse. However, it does state trials should recruit patients that represent the population that has the burden of disease in the real world.

Is it time for the UK to do the same?

The COVID-19 pandemic has exposed persisting health inequalities in the UK, and the need for effective medical research that meets the needs of those most affected.  In the current climate in the UK, more than ever, there is an urgent need to tackle systemic inequalities and under-representation of cultures, races, nationalities across all segments of industry, and society as a whole.

Furthermore, given the steps the FDA has taken to address disproportionate representation in clinical trials in the US,  this event enables organsations involved to move ahead of the curve and foster an early discussion on this issue specifically within the UK context.

Sign up to attend the discussion here: https://www.clinicaltrialdiversity.info/

8th November 2020

Share

Tags

Company Details

COUCH Health

+44 (0) 330 995 0656

Contact Website

Address:
Suite 2.10, Jactin House
24 Hood Street
Manchester
M4 6WX
United Kingdom

Latest content on this profile

New from the PhRMA: Diversity in clinical trials principles summarised
In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. The principles were approved by the PhRMA Boards of Directors and will take effect in April 2021.
COUCH Health
New from the FDA: Diversity in clinical trials guidance summarised
In November 2020, the FDA released guidance to enable greater diversity in clinical trials through changes to eligibility criteria, enrolment practices, and trial designs.
COUCH Health
5 steps to effective clinical trial branding
When recruiting patients for your clinical trial, you want the materials and information around it to be seen as reputable and professional. To make it clear what the clinical trial is about and to ensure consent is informed. And be something that people are going to remember. And with some trials lasting years, building awareness and familiarity is key to improve engagement. That’s where your clinical trial branding comes in…
COUCH Health
October 2020: diversity and inclusion in clinical trials round-up
In our latest round-up of news surrounding diversity and inclusion in clinical trials, we take a closer look into the benefits that diversity can bring to society, learnings that we can take from the COVID-19 pandemic to shift our thinking around diversity and clinical trials, how we can address long-standing barriers to build trust in healthcare, and much more.
COUCH Health
Live panel discussion: Should diverse representation in UK clinical trials be mandatory?
This online event is being held by Innovative Trials, COUCH Health, and Egality Health.  Three organisations who are working to improve diversity in clinical trials.
COUCH Health
What are the biggest barriers in patient recruitment?
With the advances that have been made in clinical research, it’s almost hard to believe that the same challenges still exist within patient recruitment. Unfortunately, traditional clinical research models pose challenges at many levels and ultimately hinder the efficient running of clinical trials.
COUCH Health